Getein Biotech (603387.SS) Stock Price

Getein Biotech Price

SSE·CLOSED
8.34CNY-0.44 (-5.14 %)
Market closed

Revenue has compounded at 18.7% per year over the past 10 years to 1.16 B CNY. Earnings per share have grown at 1.3% per year over the last 10 years. Getein Biotech's net margin stands at 19.2%, down from 27.1% several years earlier. Getein Biotech currently offers a dividend yield of about 2.28%. The payout ratio is around 43% of earnings. The stock trades about 11% above its 52-week low.

Getein Biotech stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Getein Biotech over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Getein Biotech stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Getein Biotech's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Getein Biotech Stock Price History
DateGetein Biotech Price
7/24/20268.34 CNY
7/23/20268.78 CNY
7/22/20268.63 CNY
7/21/20268.62 CNY
7/20/20268.94 CNY
7/17/20268.87 CNY
7/16/20269.25 CNY
7/15/20269.23 CNY
7/14/20268.39 CNY
7/13/20268.26 CNY
7/10/20268.28 CNY
7/9/20268.12 CNY
7/8/20268.14 CNY
7/7/20268.11 CNY
7/6/20268.33 CNY
7/3/20268.27 CNY
7/2/20268.04 CNY
7/1/20268.04 CNY
6/30/20267.56 CNY
6/29/20267.83 CNY
6/26/20267.52 CNY
6/25/20267.80 CNY
6/24/20268.10 CNY
6/23/20268.18 CNY
6/22/20267.79 CNY
6/18/20268.14 CNY
6/17/20268.14 CNY
6/16/20268.25 CNY
6/15/20268.18 CNY
6/12/20268.12 CNY
6/11/20267.90 CNY
6/10/20268.06 CNY
6/9/20268.20 CNY
6/8/20268.20 CNY
6/5/20268.54 CNY
6/4/20268.41 CNY
6/3/20268.72 CNY
6/2/20268.83 CNY
6/1/20268.99 CNY
5/29/20268.91 CNY
5/28/20268.82 CNY
5/27/20268.79 CNY
5/26/20269.01 CNY
5/25/20269.16 CNY
5/22/20269.23 CNY
5/21/20269.31 CNY
5/20/20269.37 CNY
5/19/20269.64 CNY
5/18/20269.50 CNY
5/15/20269.50 CNY
5/14/20269.66 CNY
5/13/20269.75 CNY
5/12/20269.76 CNY
5/11/202610.14 CNY
5/8/20269.88 CNY
5/7/20269.60 CNY
5/6/20269.65 CNY
4/30/20269.65 CNY
4/29/20269.15 CNY
4/28/20269.05 CNY
4/27/20269.27 CNY
4/24/20269.35 CNY
4/23/20269.33 CNY
4/22/20269.43 CNY
4/21/20269.40 CNY
4/20/20269.66 CNY
4/17/20269.46 CNY
4/16/20269.93 CNY
4/15/202610.16 CNY
4/14/20269.82 CNY
4/13/20269.98 CNY
4/10/202610.19 CNY
4/9/20269.75 CNY
4/8/202610.13 CNY
4/7/202610.29 CNY
4/3/202610.11 CNY
4/2/202610.65 CNY
4/1/202610.63 CNY
3/31/202610.02 CNY
3/30/202610.21 CNY
3/27/20269.90 CNY
3/26/20269.00 CNY
3/25/20269.17 CNY
3/24/20269.01 CNY
3/23/20268.69 CNY
3/20/20269.65 CNY
3/19/202610.20 CNY
3/18/202610.38 CNY
3/17/20269.44 CNY
3/16/20268.58 CNY
3/13/20268.35 CNY
3/12/20268.35 CNY
3/11/20268.41 CNY
3/10/20268.46 CNY
3/9/20268.40 CNY
3/6/20268.38 CNY
3/5/20268.19 CNY
2/27/20268.72 CNY
2/26/20268.70 CNY
2/25/20268.75 CNY
2/13/20268.70 CNY
2/12/20268.76 CNY
2/11/20268.88 CNY
2/10/20268.90 CNY
2/9/20268.81 CNY
2/6/20268.79 CNY
2/5/20268.59 CNY
2/4/20268.61 CNY
2/3/20268.51 CNY
2/2/20268.44 CNY
1/30/20268.63 CNY
1/29/20268.65 CNY
1/28/20268.83 CNY
1/27/20269.06 CNY
1/26/20269.21 CNY
1/23/20268.74 CNY
1/22/20268.76 CNY
1/21/20268.69 CNY
1/20/20268.64 CNY
1/19/20268.59 CNY
1/16/20268.58 CNY
1/15/20268.61 CNY
1/14/20268.78 CNY
1/13/20268.67 CNY
1/12/20268.50 CNY
1/9/20268.52 CNY
1/8/20268.47 CNY
1/7/20268.41 CNY
1/6/20268.53 CNY
1/5/20268.56 CNY
12/31/20258.40 CNY
12/30/20258.33 CNY
12/29/20258.23 CNY
12/26/20258.34 CNY
12/25/20258.30 CNY
12/24/20258.25 CNY
12/23/20258.24 CNY
12/22/20258.33 CNY
12/19/20258.35 CNY
12/18/20258.31 CNY
12/17/20258.09 CNY
12/16/20258.06 CNY
12/15/20258.10 CNY
12/12/20258.07 CNY
12/11/20258.17 CNY
12/10/20258.33 CNY
12/9/20258.33 CNY
12/8/20258.40 CNY
12/5/20258.44 CNY
12/4/20258.43 CNY
12/3/20258.49 CNY
12/2/20258.50 CNY
12/1/20258.48 CNY
11/28/20258.39 CNY
11/27/20258.37 CNY
11/26/20258.33 CNY
11/25/20258.28 CNY
11/24/20258.21 CNY
11/21/20258.11 CNY
11/20/20258.42 CNY
11/19/20258.45 CNY
11/18/20258.59 CNY
11/17/20258.65 CNY
11/14/20258.74 CNY
11/13/20258.69 CNY
11/12/20258.71 CNY
11/11/20258.62 CNY
11/10/20258.56 CNY
11/7/20258.45 CNY
11/6/20258.41 CNY
11/5/20258.40 CNY
11/4/20258.39 CNY
11/3/20258.46 CNY
10/31/20258.33 CNY
10/30/20258.10 CNY
10/29/20258.12 CNY
10/28/20258.20 CNY
10/27/20258.17 CNY
10/24/20258.14 CNY
10/23/20258.20 CNY
10/22/20258.17 CNY
10/21/20258.13 CNY
10/20/20258.04 CNY
10/17/20257.98 CNY
10/16/20258.09 CNY
10/15/20258.09 CNY
10/14/20258.00 CNY
10/13/20257.96 CNY
10/10/20258.02 CNY
10/9/20257.96 CNY
9/30/20257.98 CNY
9/29/20258.03 CNY
9/26/20258.00 CNY
9/25/20258.03 CNY
9/24/20258.10 CNY
9/23/20258.05 CNY
9/22/20258.15 CNY
9/19/20258.24 CNY
9/18/20258.28 CNY
9/17/20258.39 CNY
9/16/20258.39 CNY
9/15/20258.41 CNY
9/12/20258.50 CNY
9/11/20258.52 CNY
9/10/20258.50 CNY
9/9/20258.46 CNY
9/8/20258.55 CNY
9/5/20258.41 CNY
9/4/20258.41 CNY
9/3/20258.38 CNY
9/2/20258.43 CNY
9/1/20258.53 CNY
8/29/20258.50 CNY
8/28/20258.52 CNY
8/27/20258.62 CNY
8/26/20258.85 CNY
8/25/20258.85 CNY
8/22/20258.82 CNY
8/21/20259.01 CNY
8/20/20258.90 CNY
8/19/20258.90 CNY
8/18/20258.76 CNY
8/15/20258.76 CNY
8/14/20258.68 CNY
8/13/20258.78 CNY
8/12/20258.82 CNY
8/11/20258.79 CNY
8/8/20258.75 CNY
8/7/20258.70 CNY
8/6/20258.70 CNY
8/5/20258.78 CNY
8/4/20258.86 CNY
8/1/20258.76 CNY
7/31/20258.64 CNY
7/30/20258.70 CNY
7/29/20258.73 CNY
7/28/20258.75 CNY
Access this data via the Eulerpool API
Get Free API Key

Getein Biotech Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
686.20 M CNY
248.70 M CNY
249.60 M CNY
Jan 1, 2019
968.20 M CNY
367.60 M CNY
339.70 M CNY
Jan 1, 2020
1.12 B CNY
329.90 M CNY
304.70 M CNY
Jan 1, 2021
1.40 B CNY
423.34 M CNY
398.99 M CNY
Jan 1, 2022
1.82 B CNY
496.47 M CNY
498.91 M CNY
Jan 1, 2023
1.37 B CNY
229.29 M CNY
279.77 M CNY
Jan 1, 2024
1.16 B CNY
245.47 M CNY
223.64 M CNY
Jan 1, 2025 (e)
2.05 B CNY
0.00 CNY
512.23 M CNY

Getein Biotech Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 27, 2026, 5:43 AM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e
0.210.280.370.490.690.971.121.401.821.371.162.05
–31.4333.7032.2540.5741.1116.0124.7629.98-24.82-14.9775.86
83.8182.2581.0381.9779.0172.6263.0565.3863.1565.9667.8767.87
0.180.230.300.400.540.700.710.921.150.900.791.39
80.00108.00148.00213.00248.00367.00329.00423.00496.00229.00245.00–
38.1039.1340.1143.6536.1537.9129.3030.1927.2416.7321.05–
75.00105.00138.00194.00249.00339.00304.00398.00498.00279.00223.00512.00
–40.0031.4340.5828.3536.14-10.3230.9225.13-43.98-20.07129.60
––––0.320.290.400.260.240.400.190.18
–––––-9.3837.93-35.00-7.6966.67-52.50-5.26
194.00194.00194.00220.80260.80261.30260.50507.80509.09507.15507.15507.15
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Getein Biotech generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Getein Biotech retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Getein Biotech's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Getein Biotech has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Getein Biotech's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Getein Biotech stock margins

The Getein Biotech margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Getein Biotech. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Getein Biotech.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
79.01 %
36.24 %
36.37 %
Jan 1, 2019
72.64 %
37.97 %
35.09 %
Jan 1, 2020
63.11 %
29.37 %
27.13 %
Jan 1, 2021
65.37 %
30.20 %
28.46 %
Jan 1, 2022
63.14 %
27.25 %
27.38 %
Jan 1, 2023
66.01 %
16.75 %
20.43 %
Jan 1, 2024
67.86 %
21.07 %
19.20 %
Jan 1, 2025 (e)
67.86 %
0.00 %
25.02 %

Getein Biotech Stock Revenue, EBIT, Earnings per Share

The Getein Biotech earnings per share therefore indicates how much revenue Getein Biotech has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
2.63 CNY
0.95 CNY
0.96 CNY
Jan 1, 2019
3.71 CNY
1.41 CNY
1.30 CNY
Jan 1, 2020
4.31 CNY
1.27 CNY
1.17 CNY
Jan 1, 2021
2.76 CNY
0.83 CNY
0.79 CNY
Jan 1, 2022
3.58 CNY
0.98 CNY
0.98 CNY
Jan 1, 2023
2.70 CNY
0.45 CNY
0.55 CNY
Jan 1, 2024
2.30 CNY
0.48 CNY
0.44 CNY
Jan 1, 2025 (e)
4.04 CNY
0.00 CNY
1.01 CNY

Getein Biotech business model & stock analysis

Getein Biotech Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Getein Biotech historical P/E ratio, EBIT multiple, and P/S ratio

Getein Biotech annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Getein Biotech shares outstanding

The number of shares of Getein Biotech was 507.15 M in 2025. This indicates how many shares Getein Biotech is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
260.80 M Stocks
Jan 1, 2019
261.30 M Stocks
Jan 1, 2020
260.50 M Stocks
Jan 1, 2021
507.80 M Stocks
Jan 1, 2022
509.09 M Stocks
Jan 1, 2023
507.15 M Stocks
Jan 1, 2024
507.15 M Stocks
Jan 1, 2025 (e)
507.15 M Stocks

Getein Biotech stock splits

In Getein Biotech's history, there have been no stock splits.

Getein Biotech Dividend History

8 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.18CNY↓ 5.3%2×
Jun 17, 20250.09CNY 0.0%1/2
Sep 15, 20250.09CNY 0.0%2/2
20240.19CNY↓ 52.5%2×
20230.40CNY↑ 64.7%2×
20220.24CNY↓ 5.6%1×
20210.26CNY↓ 35.7%1×
20200.40CNY↑ 36.6%1×
20190.29CNY↓ 8.9%1×
20180.32CNY—1×

Getein Biotech dividend history and estimates

In 2025, Getein Biotech paid a dividend amounting to 0.18 CNY. Dividend means that Getein Biotech distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2018
0.32 CNY
0.00 CNY
Jan 1, 2019
0.29 CNY
0.00 CNY
Jan 1, 2020
0.40 CNY
0.00 CNY
Jan 1, 2021
0.26 CNY
0.00 CNY
Jan 1, 2022
0.24 CNY
0.00 CNY
Jan 1, 2023
0.40 CNY
0.00 CNY
Jan 1, 2024
0.19 CNY
0.00 CNY
Jan 1, 2025
0.18 CNY
0.00 CNY

Getein Biotech dividend payout ratio

In 2025, Getein Biotech had a payout ratio of 17.82%. The payout ratio indicates the percentage of the company's profits that Getein Biotech distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2018
12.20 %
Jan 1, 2019
11.49 %
Jan 1, 2020
17.44 %
Jan 1, 2021
23.38 %
Jan 1, 2022
34.69 %
Jan 1, 2023
72.50 %
Jan 1, 2024
43.08 %
Jan 1, 2025 (e)
17.82 %
Price targets and forecasts for Getein Biotech are not yet available.

Getein Biotech shareholder structure

% Name
39.76514%
Su (Enben)
Su (Enben)
3.46006%
Nanjing Aiji Business Information Consulting Co., Ltd.
Nanjing Aiji Business Information Consulting Co., Ltd.
1.56818%
Xiao (Guo Hua)
Xiao (Guo Hua)
1.13544%
Gao (Jian)
Gao (Jian)
0.90343%
Huang (Guoyu)
Huang (Guoyu)
0.84753%
Su (Enkui)
Su (Enkui)

Getein Biotech Executives and Management Board

BY

Mr. Bin Yan

(40)

Deputy General Manager, Director · since 2014

Compensation775,500.00 CNY
TK

Ms. Tingting Kong

(38)

Deputy General Manager, Director · since 2018

Compensation680,000.00 CNY
WN

Mr. Wen Ni

(39)

Chief Financial Officer, Director · since 2017

Compensation568,000.00 CNY
ES

Mr. Enkui Su

(60)

Director

Compensation389,800.00 CNY
CL

Ms. Cong Liu

(36)

Secretary of the Board

Compensation342,500.00 CNY

Frequently asked questions about Getein Biotech

5 analysts currently rate the Getein Biotech stock: 4 recommend buying, 1 holding and 0 selling.

Getein Biotech Analyst Price Targets 2026

All fundamentals and in-depth analysis of Getein Biotech

Our stock analysis for Getein Biotech stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Getein Biotech. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Getein Biotech Stock
Getein Biotech Revenue→
Getein Biotech Stock
Getein Biotech Net Income→
Getein Biotech Stock
Getein Biotech P/E→
Getein Biotech Stock
Getein Biotech P/S→
Getein Biotech Stock
Getein Biotech EBIT→
Getein Biotech Stock
Getein Biotech Dividend→
Getein Biotech Stock
Getein Biotech Directors Dealings→
Getein Biotech Stock
Getein Biotech Stocks→
Getein Biotech Stock
Getein Biotech Market capitalization→
Getein Biotech Stock
Getein Biotech Debt→
Getein Biotech Stock
Getein Biotech Liabilities→
Getein Biotech Stock
Getein Biotech Equity→
Getein Biotech Stock
Getein Biotech AAQS→
Getein Biotech Stock
Getein Biotech Employees→
Getein Biotech Stock
Getein Biotech ROE→
Getein Biotech Stock
Getein Biotech ROA→
Getein Biotech Stock
Getein Biotech ROCE→
Getein Biotech Stock
Getein Biotech News→
Getein Biotech Stock
Getein Biotech Analyst Price Targets→

Health Stocks

GetingeGesundheitswelt ChiemgauGH ResearchGerresheimerGI InnovationGeronGian Life CareGeratherm MedicalGilead SciencesGeoVax LabsGinwa Enterprise GroupGenusAll Stocks A–Z →